裕承科金(00279.HK):與解決方案提供商訂立資訊科技基礎設施合約
格隆匯7月2日丨裕承科金(00279.HK)公佈,2023年6月30日,公司全資附屬公司ARTA與解決方案提供商Emali Limited訂立資訊科技基礎設施合約,委任解決方案提供商為技術解決方案提供商以開發及交付與項目有關的可交付成果。
根據資訊科技基礎設施合約,解決方案將提供商幫助ARTA設計、構建及部署前端與後端資訊科技基礎設施,該等設施支持(其中包括)CBDC的電子錢包託管、CBDC支付服務及利用CBDC投資,納入用户引導、私隱保護及安全功能。資訊科技基礎設施合約項下可交付成果的開發及交付將入賬列作公司的一項投資。此外,預期透過該投資,集團將具備提供項目下具有金融應用的技術解決方案的技術能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.